Press Releases

All Releases
View Summary Dendreon Announces Expiration of Bid Deadline In Connection With Agreement to Sell Substantially All Assets to Valeant
Feb 10, 2015
PDF 12.6 KB
View Summary Dendreon Enters into Amended Agreement with Valeant in Connection with Court-Supervised Sales Process
Feb 5, 2015
PDF 11.9 KB
View Summary Dendreon Reaches Agreement For Valeant To Serve As "Stalking Horse Bidder" In Court-Supervised Sales Process
Jan 29, 2015
PDF 12.6 KB
View Summary Dendreon Provides Update on Restructuring Process
Jan 27, 2015
PDF 11.3 KB
View Summary Dendreon Announces Strong Commercial Start to 2015
Jan 14, 2015
PDF 15.6 KB
View Summary Dendreon Reaches Agreements on Terms of Financial Restructuring
Nov 10, 2014
PDF 14.9 KB
View Summary Dendreon Names W. Thomas Amick President and Chief Executive Officer
Jul 30, 2014
PDF 11.8 KB
View Summary Dendreon Announces Leadership Transition
Jun 9, 2014
PDF 12.6 KB
View Summary Treatment with PROVENGE® (sipuleucel-T) Induces Antigen Spread Associated with Overall Survival Benefits In Advanced Prostate Cancer
May 20, 2014
PDF 16.5 KB
View Summary Dendreon Announces Presentation of PROVENGE® (sipuleucel-T) and DN24-02 Immuno-Oncology Data at the 2014 ASCO Annual Meeting
May 14, 2014
PDF 18.0 KB
View Summary Dendreon Announces First Quarter 2014 Results
May 8, 2014
PDF 25.5 KB
View Summary Dendreon to Host Conference Call on May 8 to Announce First Quarter Financial Results
Apr 28, 2014
PDF 10.5 KB
View Summary Immune Responses Enhanced and Sustained When PROVENGE® (sipuleucel-T) is Given After Androgen Deprivation Therapy in Biochemically-Recurrent Prostate Cancer
Apr 11, 2014
PDF 15.5 KB
View Summary Dendreon Announces Plans to Make PROVENGE® Commercially Available in Europe
Mar 3, 2014
PDF 14.1 KB
View Summary Dendreon Announces Fourth Quarter and 2013 Year End Results
Mar 3, 2014
PDF 29.9 KB
View Summary Dendreon Announces Webcast Presentation at Cowen and Company Health Care Conference
Feb 20, 2014
PDF 9.4 KB
View Summary Dendreon to Host Conference Call on March 3 to Announce Fourth Quarter and Full Year 2013 Financial Results
Feb 14, 2014
PDF 10.5 KB
View Summary Dendreon Announces Presentation of PROVENGE® (sipuleucel-T) Data at the 2014 Genitourinary Cancer Symposium (ASCO GU)
Jan 30, 2014
PDF 68.8 KB
View Summary Dendreon Announces Preliminary Fourth Quarter 2013 Revenues
Jan 13, 2014
PDF 15.8 KB
View Summary Dendreon Announces Change to Presentation Date and Time at J.P. Morgan Healthcare Conference
Jan 9, 2014
PDF 9.5 KB
Showing 1-20 of 445 Page: 1 2 3 4 5 ... 23  Next 20